Probiotic and Prebiotic Supplementation in Elite Athletes With Spinal Cord Injury
Primary Purpose
Spinal Cord Injuries
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
Multistrain probiotic preparation
Oat Bran
Sponsored by
About this trial
This is an interventional prevention trial for Spinal Cord Injuries focused on measuring probiotic supplementation, prebiotic supplementation
Eligibility Criteria
Inclusion Criteria:
- athletes with a spinal cord injury shortlisted as potential participants for major international events, such as the Paralympic Games 2021 in Tokyo and World Championship qualification
Exclusion Criteria:
- Chronic inflammatory bowel diseases (i.e. ulcerative colitis, Crohn's disease)
- Taking antibiotics and/or other medication to alleviate gastrointestinal complaints at recruitment time point
- Pregnancy
Sites / Locations
- Swiss Paraplegic Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Bactosan - oat bran
Oat bran - Bactosan
Arm Description
This group will receive Bactosan first, followed by oat bran.
This group will receive oat bran first, followed by Bactosan.
Outcomes
Primary Outcome Measures
Recruitment rate
Proportion of invited participants who agreed to participate in the trial
Dropout rate
The proportion of randomized participants who did not complete the study protocol
Severe adverse events
The occurrence of severe adverse events (SAEs)
Secondary Outcome Measures
Gastrointestinal problems
Assessed using the Gastrointestinal Quality of Life Index (GIQLI) of Eypasch, using a 5-point scale (0-4) with total range 0-144 and higher scores indicating better outcomes.
Stool microbiome characterization
Stool probes will be sampled by the participants at home and send to the study center. The "What's in my Pot?" (WIMP) workflow (Oxford Nanopore Technologies) will be used to classify and identify species in real time, generating a graphical WIMP report of the sample composition and the most reliable placement in the taxonomy tree, assigning a score to each taxonomic placement.
Monitoring of inflammation
C-reactive protein (CRP) from blood samples in mg/L
Loss of training days due to injury or illness
Assessed using the Oslo Sports Trauma Research Centre (OSTRC) Overuse Injury Questionnaire, which consists of several multiple choice and open questions (no scale).
Food intake during three days
Self-reported intake (content and quantity) of food on a data sheet, including photo's. Calculations of the nutritional quality and quantity of consumed foods, drinks and nutritional supplements will be performed using PRODI® Swiss, a computer program for nutritional counselling and nutritional therapy.
Recording of leisure time activity
Assessed using the Leisure Time Physical Activity Questionnaire (LTPA-Q), which records number of days and minutes of physical activity (no scale).
Full Information
NCT ID
NCT04659408
First Posted
November 24, 2020
Last Updated
December 14, 2021
Sponsor
Swiss Paraplegic Research, Nottwil
1. Study Identification
Unique Protocol Identification Number
NCT04659408
Brief Title
Probiotic and Prebiotic Supplementation in Elite Athletes With Spinal Cord Injury
Official Title
The Effect of Probiotic and Prebiotic Supplementation on Gastrointestinal Comfort in Elite Athletes With Spinal Cord Injury: A Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
March 1, 2021 (Actual)
Primary Completion Date
October 29, 2021 (Actual)
Study Completion Date
October 29, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Swiss Paraplegic Research, Nottwil
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main objective of this pilot study is to obtain information, which will be used for the design of a main randomized controlled trial (RCT) with a larger size based on feasibility, validity and sample size estimation as well as the potential effects of pre- and probiotic intake on intestinal microbiota. A larger trial will then be designed to test the hypothesis that adding probiotics or prebiotics may improve gut microbiome composition, gastrointestinal symptoms as well as cardiometabolic health indices in mid-term and possibly lead to improved sports performance over a longer-term period in athletes with a Spinal Cord Injury.
Detailed Description
In this pilot crossover randomized controlled trial, twenty (N = 20) para-athletes will participate in an intervention consisting of a four-week intake of probiotic, using the commercially available multistrain probiotic preparation "BactoSan pro FOS" from Mepha (Basel, Switzerland), followed by a four-week wash-out period, and a four-week prebiotic intervention using "Naturaplan Bio Oat Bran" (Coop, Switzerland). Total duration of the study will be 16 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries
Keywords
probiotic supplementation, prebiotic supplementation
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Randomized controlled trial with within-participants crossover
Masking
None (Open Label)
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Bactosan - oat bran
Arm Type
Experimental
Arm Description
This group will receive Bactosan first, followed by oat bran.
Arm Title
Oat bran - Bactosan
Arm Type
Experimental
Arm Description
This group will receive oat bran first, followed by Bactosan.
Intervention Type
Dietary Supplement
Intervention Name(s)
Multistrain probiotic preparation
Other Intervention Name(s)
BactoSan pro FOS (Mepha, Switzerland)
Intervention Description
One sachet daily, containing 3 grams of the freeze-dried multispecies probiotic Bactosan for a period of four weeks. One sachet will be mixed with 50-100 ml water and taken daily before breakfast or dinner. Bactosan contains the following eight bacterial strains: Bifidobacterium lactis W51, Bifidobacterium lactis W52, Enterococcus faecium W54, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Lactobacillus plantarum W21, Lactobacillus salivarius W24 and Lactococcus lactis W19, with a total viable cell count of 1 × 109 cfu/gram, and therefore 3 × 109 cfu/daily dose.
Intervention Type
Dietary Supplement
Intervention Name(s)
Oat Bran
Other Intervention Name(s)
Naturaplan Organic Oat Bran (Coop, Switzerland)
Intervention Description
5 grams (one teaspoon) daily of the oat bran together with a meal of preference. The oat bran can be added to the usual breakfast cereal, yoghurt, pancakes, juice, milk, salad sauce or in an omelette.
Primary Outcome Measure Information:
Title
Recruitment rate
Description
Proportion of invited participants who agreed to participate in the trial
Time Frame
At baseline
Title
Dropout rate
Description
The proportion of randomized participants who did not complete the study protocol
Time Frame
Through study completion, an average of 4 months
Title
Severe adverse events
Description
The occurrence of severe adverse events (SAEs)
Time Frame
Through study completion, an average of 4 months
Secondary Outcome Measure Information:
Title
Gastrointestinal problems
Description
Assessed using the Gastrointestinal Quality of Life Index (GIQLI) of Eypasch, using a 5-point scale (0-4) with total range 0-144 and higher scores indicating better outcomes.
Time Frame
At 0, 1, 2, 3 months
Title
Stool microbiome characterization
Description
Stool probes will be sampled by the participants at home and send to the study center. The "What's in my Pot?" (WIMP) workflow (Oxford Nanopore Technologies) will be used to classify and identify species in real time, generating a graphical WIMP report of the sample composition and the most reliable placement in the taxonomy tree, assigning a score to each taxonomic placement.
Time Frame
At 0, 1, 2, 3 months
Title
Monitoring of inflammation
Description
C-reactive protein (CRP) from blood samples in mg/L
Time Frame
At 0, 1, 2, 3 months
Title
Loss of training days due to injury or illness
Description
Assessed using the Oslo Sports Trauma Research Centre (OSTRC) Overuse Injury Questionnaire, which consists of several multiple choice and open questions (no scale).
Time Frame
At 0, 1, 2, 3 months
Title
Food intake during three days
Description
Self-reported intake (content and quantity) of food on a data sheet, including photo's. Calculations of the nutritional quality and quantity of consumed foods, drinks and nutritional supplements will be performed using PRODI® Swiss, a computer program for nutritional counselling and nutritional therapy.
Time Frame
At 0, 1, 2, 3 months
Title
Recording of leisure time activity
Description
Assessed using the Leisure Time Physical Activity Questionnaire (LTPA-Q), which records number of days and minutes of physical activity (no scale).
Time Frame
At 0, 1, 2, 3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
athletes with a spinal cord injury shortlisted as potential participants for major international events, such as the Paralympic Games 2021 in Tokyo and World Championship qualification
Exclusion Criteria:
Chronic inflammatory bowel diseases (i.e. ulcerative colitis, Crohn's disease)
Taking antibiotics and/or other medication to alleviate gastrointestinal complaints at recruitment time point
Pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joëlle Flück, PhD
Organizational Affiliation
Sports nutrition expert
Official's Role
Principal Investigator
Facility Information:
Facility Name
Swiss Paraplegic Centre
City
Nottwil
State/Province
Luzern
ZIP/Postal Code
6207
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
35477496
Citation
Glisic M, Flueck JL, Ruettimann B, Hertig-Godeschalk A, Valido E, Bertolo A, Stucki G, Stoyanov J. The feasibility of a crossover, randomized controlled trial design to assess the effect of probiotics and prebiotics on health of elite Swiss para-athletes: a study protocol. Pilot Feasibility Stud. 2022 Apr 27;8(1):94. doi: 10.1186/s40814-022-01048-6.
Results Reference
derived
Learn more about this trial
Probiotic and Prebiotic Supplementation in Elite Athletes With Spinal Cord Injury
We'll reach out to this number within 24 hrs